These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25123403)

  • 1. Why is kernicterus still a major cause of death and disability in low-income and middle-income countries?
    Olusanya BO; Ogunlesi TA; Slusher TM
    Arch Dis Child; 2014 Dec; 99(12):1117-21. PubMed ID: 25123403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facility-based constraints to exchange transfusions for neonatal hyperbilirubinemia in resource-limited settings.
    Mabogunje CA; Olaifa SM; Olusanya BO
    World J Clin Pediatr; 2016 May; 5(2):182-90. PubMed ID: 27170928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for severe neonatal hyperbilirubinemia in low and middle-income countries: a systematic review and meta-analysis.
    Olusanya BO; Osibanjo FB; Slusher TM
    PLoS One; 2015; 10(2):e0117229. PubMed ID: 25675342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances to diminish global newborn kernicterus mortality.
    Bhutani VK; Vidavalur R; Wong RJ
    J Perinatol; 2024 Apr; 44(4):493-500. PubMed ID: 38151598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of severe neonatal jaundice: a systematic review and meta-analysis.
    Slusher TM; Zamora TG; Appiah D; Stanke JU; Strand MA; Lee BW; Richardson SB; Keating EM; Siddappa AM; Olusanya BO
    BMJ Paediatr Open; 2017; 1(1):e000105. PubMed ID: 29637134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical strategies for preventing toxicity and promoting antioxidant and anti-inflammatory actions of bilirubin.
    Nocentini A; Bonardi A; Pratesi S; Gratteri P; Dani C; Supuran CT
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):487-501. PubMed ID: 34986721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disability and mortality in LMICs: why we need to know more.
    Groce NE
    Lancet Glob Health; 2024 May; 12(5):e713-e714. PubMed ID: 38614619
    [No Abstract]   [Full Text] [Related]  

  • 8. Correction: Advances to diminish global newborn kernicterus mortality.
    Bhutani VK; Vidavalur R; Wong RJ
    J Perinatol; 2024 Apr; 44(4):600-601. PubMed ID: 38383576
    [No Abstract]   [Full Text] [Related]  

  • 9. Why does the UK continue to trail other high income countries in health outcomes?
    Wise J
    BMJ; 2023 Nov; 383():2642. PubMed ID: 37949467
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperbilirubinemia, hemolysis, and increased bilirubin neurotoxicity.
    Kaplan M; Bromiker R; Hammerman C
    Semin Perinatol; 2014 Nov; 38(7):429-37. PubMed ID: 25284470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of late-preterm and term infants with hyperbilirubinaemia in resource-constrained settings.
    Olusanya BO; Ogunlesi TA; Kumar P; Boo NY; Iskander IF; de Almeida MF; Vaucher YE; Slusher TM
    BMC Pediatr; 2015 Apr; 15():39. PubMed ID: 25884679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancing the newborn and stillbirth global agenda: priorities for the next decade.
    Darmstadt GL; Shiffman J; Lawn JE
    Arch Dis Child; 2015 Feb; 100 Suppl 1():S13-8. PubMed ID: 25613960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The propre-save study: effects of probiotics and prebiotics alone or combined on necrotizing enterocolitis in very low birth weight infants.
    Dilli D; Aydin B; Fettah ND; Özyazıcı E; Beken S; Zenciroğlu A; Okumuş N; Özyurt BM; İpek MŞ; Akdağ A; Turan Ö; Bozdağ Ş
    J Pediatr; 2015 Mar; 166(3):545-51.e1. PubMed ID: 25596096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose induces intestinal human UDP-glucuronosyltransferase (UGT) 1A1 to prevent neonatal hyperbilirubinemia.
    Aoshima N; Fujie Y; Itoh T; Tukey RH; Fujiwara R
    Sci Rep; 2014 Sep; 4():6343. PubMed ID: 25209391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates of Extreme Neonatal Hyperbilirubinemia and Kernicterus in Children and Adherence to National Guidelines for Screening, Diagnosis, and Treatment in Sweden.
    Alkén J; Håkansson S; Ekéus C; Gustafson P; Norman M
    JAMA Netw Open; 2019 Mar; 2(3):e190858. PubMed ID: 30901042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental influence of unconjugated hyperbilirubinemia and neurobehavioral disorders.
    Amin SB; Smith T; Timler G
    Pediatr Res; 2019 Jan; 85(2):191-197. PubMed ID: 30397278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal hyperbilirubinaemia: a global perspective.
    Olusanya BO; Kaplan M; Hansen TWR
    Lancet Child Adolesc Health; 2018 Aug; 2(8):610-620. PubMed ID: 30119720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Neurological Sequelae of Neonatal Hyperbilirubinemia: Definitions, Diagnosis and Treatment of the Kernicterus Spectrum Disorders (KSDs).
    Le Pichon JB; Riordan SM; Watchko J; Shapiro SM
    Curr Pediatr Rev; 2017; 13(3):199-209. PubMed ID: 28814249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal jaundice: aetiology, diagnosis and treatment.
    Mitra S; Rennie J
    Br J Hosp Med (Lond); 2017 Dec; 78(12):699-704. PubMed ID: 29240507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-6-Phosphate Dehydrogenase Deficiency and the Need for a Novel Treatment to Prevent Kernicterus.
    Cunningham AD; Hwang S; Mochly-Rosen D
    Clin Perinatol; 2016 Jun; 43(2):341-54. PubMed ID: 27235212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.